Pathogenesis of osteoporosis

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 14, Issue 2, 2000, Pages 181-193

  Rosen, Clifford J ^a,b  

^a Jackson Library   (United States)

^b ST JOSEPH HOSPITAL   (United States)

Author keywords

Bone mass; Bone remodelling; Insulin like growth factor; Osteoblasts; Osteoclasts; Osteoporosis; Osteoprotogerin

Indexed keywords

ANDROGEN; CALCITRIOL; CALCIUM; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOSPORIN; ESTRADIOL; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; OSTEOPROTEGERIN; PARATHYROID HORMONE; PREDNISONE; SOMATOMEDIN; STEROID; TESTOSTERONE; VITAMIN D;

BONE ATROPHY; BONE MASS; BONE MINERALIZATION; BONE REMODELING; CALCIUM DEFICIENCY; CALCIUM INTAKE; CLINICAL TRIAL; DIETARY INTAKE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; HERITABILITY; HUMAN; HYPERCALCIURIA; HYPOGONADISM; MUSCLE ATROPHY; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; REVIEW; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; TESTOSTERONE BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 0033762970     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2000.0068     Document Type: Article

References (55)

1. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. New England Journal of Medicine 1995; 332: 767-773.
2. Kanis JA, Melton LJ, Christiansen C et al. The diagnosis of osteoporosis. Journal of Bone and Mineral Research 1994; 9: 1137-1141.
3. Stewart A, Walker LG, Potter RW et al. Prediction of a second hip fracture: the potential role of DXA, ultrasound, and other risk factors for targeting of preventative therapy. Journal of Clinical Densitometry 1999; 2: 363-371.
4. Tinetti ME, Speechely M & Gunter SF. Risk factors for falls among elderly persons living in the community. New England Journal of Medicine 1988; 319: 1701-1707.
5. Miller PD. Guidelines for the clinical utilization of bone mass measurements in the adult population. Calcified Tissue International 1995; 57: 252-265.
6. Riggs BL, Wahner HW & Seeman E. Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes. Journal of Clinical Investigation 1982; 70: 716-723.
7. Lian JB & Stein GS. The cells of bone. In Seibel MJ, Robbins S & Bilezikian JP (eds) Principles of Bone and Cartilage Metabolism, pp 165-185. San Diego: Academic Press, 1999.
8. Lorenzo JA & Raisz LG. Cytokines and prostaglandins. In Seibel MJ, Robbins S & Bilezikian JP (eds) Principles of Bone and Cartilage Metabolism, pp 97-109. San Diego: Academic Press, 1999.
9. Udagawa N, Takahashi N, Jimi E et al. Osteoblasts/stromal cells stimulate osteoclast differentiation factor/RANKL but not macrophage colony stimulating factor. Bone 1999; 25: 517-523.
10. Emery JG, McDonnell P, Burke MB et al. Osteoprotegrin is a receptor for the cytotoxic ligand TRAIL. Journal of Biological Chemistry 1998; 273: 14363-14367.
11. Suda T, Takahashi N & Martin TJ. Modulation of osteoclast differentiation. Endocrine Reviews 1992; 12: 66-80.
12. Ducy P, Zhang RR, Geoffroy V et al. Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
13. Rosen CJ. Growth hormone, IGF-I and the elderly: clues to potential therapeutic intervention. Endocrine 1997; 7: 39-40.
14. Albright F. Postmenopausal osteoporosis. Journal of the American Medical Association 1941; 116: 2465-2474.
15. Chestnust C, Notelovitz M, Clark G et al. Use of the N-telopeptide of type 1 collagen to monitor the effect of therapy and predict changes in bone mineral density in postmenopausal women treated with hormone replacement therapy. American Journal of Medicine 1997; 102: 29-37.
16. Ettinger B, Pressman A, Sklarin P et al. Associations between low levels of serum estradiol, bone density and fractures among elderly women: SOF. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2239-2243.
17. Greendale GA, Edelstein S & Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men. Journal of Bone and Mineral Research 1997; 12: 1833-1837.
18. Smith EP, Boyd J, Frank GR et al. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. New England Journal of Medicine 1994; 331: 1056-1061.
19. Morishima A, Grumbach MM, Simpson ER et al. Aromatase deficiency in male and female siblings caused by a novel mutation in the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995; 80: 3689-3698.
20. Carani C, Quin K, Simoni M et al. Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine 1997; 337: 91-95.
21. Jilka RG, Girsole GH, Passeri G et al. Increased osteoclast development after estrogen loss: mediation by IL-6. Science 1992; 257: 88-91.
22. Pacifici R, Brown C & Puscheck E. The effect of surgical menopause and estrogen replacement on cytokine release from human blood monocytes. Proceedings of the National Academy of Sciences of the USA 1991; 88: 5134-5138.
23. Manolagas SC & Jilka RL. Emerging insights into the pathophysiology of osteoporosis. New England Journal of Medicine 1995; 332: 305-311.
24. Snyder PJ, Peachey H, Hannoush P et al. Effect of testosterone treatment on body composition and muscle strength in men over 65. Journal of Clinical Endocrinology and Metabolism 1999; 84: 2647-2653.
25. Dresner-Pollak R, Parker RA, Poku M et al. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcified Tissue International 1996; 59: 328-333.
26. Food and Nutrition Board Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academy Press, 1997.
27. Storm D, Smith-Porter E, Musgrave KO et al. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 1998; 83: 3817-3826.
28. Rosen CJ, Morrison A, Zhou H et al. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone and Mineral 1994; 25: 83-92.
29. Holick MF. Vitamin D: new horizons for the 21st century. Journal of Nutrition 1996; 124: 11595-11645.
30. LeBoff MS, Kohlmeier L, Hurwitz S et al. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. Journal of the American Medical Association 1999; 282: 1505-1511.
31. Rosen C, Donahue LR, Hunter S et al. The 24/25kD serum insulin-like growth factor binding protein is increased in elderly women with fractures. Journal of Clinical Endocrinology and Metabolism 1992; 74: 24-28.
32. Heaney RP, McCarron DA, Dawson Hughes B et al. Dietary changes favorably affect bone remodeling in older adults. Journal of the American Dieretic Association 1999; 99: 1228-1233.
33. Cushing H. Basophile adenomas of the pituitary body and their clinical manifestations. Bulletin of the Johns Hopkins Hospital 1932; 50: 137-145.
34. Rosen CJ & Adler RA. Glucorticoids and bone mass. Clinics in Endocrinology and Metabolism 1994; 23: 641-654.
35. Reid IR, Veale AG & France JT. Glucocorticoid osteoporosis. Journal of Asthma 1994; 31: 7-18.
36. Teegarden D, Proulx WR & Martin BR. Peak bone mass in young women. Journal of Bone and Mineral Research 1995; 10: 711-715.
37. Gilsanz V, Loro ML, Roe TF et al. Gender differences in vertebral size in adults: biomechanical implications. Journal of Clinical Investigation 1995; 95: 2332-2337.
38. Bachrach LK, Guido D, Katzman D et al. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990; 86: 440-447.
39. Prior JC, Vigna Y, Schechter MT & Burgess AE. Spinal bone loss and ovulatory disturbances. New England Journal of Medicine 1990; 323: 1221-1227.
40. Finkelstein JS, Neer RM, Biller BMK et al. Osteopenia in men with a history of delayed puberty. New England Journal of Medicine 1992; 326: 600-604.
41. Mora S, Pitukcheewanont P, Nelson JC & Gilsanz V. Serum levels of IGF-1 and the density volume and cross-sectional area of bone in children. Journal of Clinical Endocrinology and Metabolism 1999; 84: 2780-2783.
42. Bing-You RG, Denis MC & Rosen CJ. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlation with growth hormone, responses to GHRH, IGF-1 and IGFBP-3. Calcified Tissue International 1993; 52: 183-187.
43. Rosen CJ, Dimai HP, Vereault D et al. Circulating and skeletal IGF-1 concentrations in two inbred strains of mice with different bone densities. Bone 1997; 21(3): 217-223.
44. Beamer WG, Donahue LR, Rosen CJ & Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 1996; 18(5): 397-405.
45. Menaa C, Vrtovsnik F, Freidlander G et al. IGF-1 a unique calcium dependent stimulator of 1,25 vitamin D production. Journal of Biological Chemistry 1995; 270: 25461-25467.
46. Johnston CC, Miller JZ, Slemenda CW et al. Calcium supplementation and increases in bone mineral density in children. New England Journal of Medicine 1992; 327: 82-87.
47. McKay HA, Bailey DA, Wilkinson AA & Houston CS. Familial comparison of bone mineral density at the proximal femur and lumbar spine. Bone and Mineral 1994; 24: 95-107.
48. Smith DM, Nance WE, Kang KW et al. Genetic factors in determining bone mass. Journal of Clinical Investigation 1973; 52: 2800-2808.
49. Seeman E. Genetic determinants of the population variance in bone mineral density. In Rosen CJ, Glowacki J & Bilezikian JP (eds) The Aging Skeleton, pp 77-84. San Diego: Academic Press, 1999.
50. Rogers J, Mahaney MC, Beamer WG et al. Beyond one gene-one disease: alternative strategies for deciphering genetic determinants of osteoporosis. Calcified Tissue International 1997; 60: 225-228.
51. Ralston SH. The genetics of osteoporosis. Quarterly Journal of Medicine 1997; 90: 247-251.
52. Utterlinden AG, Burger H, Huang Q et al. Relation of alleles of the collagen type 1 alpha 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. New England Journal of Medicine 1998; 338: 1016-1021.
53. Bonjour JP, Carrie AL & Ferrari S. Calcium enriched foods and bone mass growth in prepubertal girls: a randomized double blind placebo controlled trial. Journal of Clinical Investigation 1997; 99: 1287-1294.
54. Cadogan J, Blumsehn A, Barker M & Eastell R. A longitudinal study of bone gain in pubertal girls: anthropometric and biochemical correlates. Journal of Bone and Mineral Research 1998; 13: 1602-1612.
55. Weaver CM, Peacock M & Johnston CC. Adolescent nutrition in the prevention of postmenopausal osteoporosis. Journal of Clinical Endocrinology and Metabolism 1999; 84: 1839-1843.